When was the most recent $SMNR (Semnur Pharmaceuticals, Inc.) SEC filing?

The latest tracked SEC EDGAR filing for Semnur Pharmaceuticals, Inc. ($SMNR) was filed on November 5, 2026, with 0 high-impact or featured filings flagged by Position Tracker's AI analysis.

$SMNR SEC EDGAR Filings Hub 1 Filing

$SMNR · Semnur Pharmaceuticals, Inc. SEC Filings

Q: What SEC filings are tracked for $SMNR (Semnur Pharmaceuticals, Inc.)?

Position Tracker indexes 1 SEC EDGAR filings for Semnur Pharmaceuticals, Inc. ($SMNR), including 0 Form 10-K annual reports, 1 Form 10-Q quarterly reports, 0 Form 8-K material event disclosures, and 0 Form 4 insider buying and selling filings.

Position Tracker tracks 1 SEC EDGAR filings for Semnur Pharmaceuticals, Inc. ($SMNR) from November 5, 2026 through November 5, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 0 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.

Check $SMNR portfolio concentration → View $SMNR Congress trades → Research $SMNR stock → All SEC filings →

Total Filings1

10-K / 10-Q Reports1

8-K Material Events0

Form 4 Insider0

High-Impact0

Latest FilingNovember 5, 2026

Browse SEC Filings by Form Type

Form 4 Form 8-K Form 10-K Form 10-Q Schedule 13D/13G Form 13F Form S-1 Form 6-K

Latest $SMNR SEC Filings & AI Summaries (1)

$SMNR Form 10-Q Impact 6/10 10-Q

November 4, 2026